Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ADCT — ADC Therapeutics SA

CIK 884546 SAN FRANCISCO, CA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$239,742
-$601,611 QoQ
Shares Held
224,058
-0.1% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 113 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. ADCT ranks #40 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 4,003,981 $287,726,073
2 VTRS
Viatris Inc
 13,567,342 $215,449,390
3 NBIX
Neurocrine Biosciences Inc
 974,279 $164,204,982
4 UTHR
UNITED THERAPEUTICS Corp
 297,162 $161,011,285
5 ALKS
Alkermes plc.
 2,335,117 $122,360,130
6 ELAN
Elanco Animal Health Inc
 3,553,213 $87,444,571
7 HIMS
Hims & Hers Health, Inc.
 2,453,787 $85,072,795
8 LNTH
Lantheus Holdings, Inc.
 665,457 $73,825,799

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $239,742 224,058
2026-03-31 $841,353 224,361
2025-12-31 $750,718 212,668
2025-09-30 $728,048 182,012
2025-06-30 $487,792 182,012
2025-03-31 $273,903 194,258
2024-12-31 $386,573 194,258
2024-09-30 $611,912 194,258
2024-06-30 $554,459 175,462